Sun Pharma, Teva to settle patent suit tied to acid-reflux med for $2.15B

06/13/2013 | Reuters

Teva Pharmaceutical Industries and Sun Pharmaceutical Industries agreed to settle a patent-infringement lawsuit connected to Pfizer and Takeda Pharmaceutical's acid-reflux treatment Protonix for $2.15 billion. The two makers of generic drugs are accused of marketing a copy of an existing treatment with unexpired patents. "It is an important milestone, setting a 'book-end' case for the industry," said Bernstein Research analyst Aaron Gal. "It will serve to encourage patent settlements."

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC